Home › Heart Failure › South Carolina › North Charleston
Heart Failure clinical trials in North Charleston, SC
3 studies for Heart Failure are looking for participants at sites in and around North Charleston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
RecruitingPhase 3
- Research Site, North Charleston
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
RecruitingPhase 3
- MUSC Shawn Jenkins Children's Hospital - Cardiology, North Charleston
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
RecruitingPhase 3
- MUSC Shawn Jenkins Children's Hospital - Cardiology, North Charleston
About Heart Failure
Heart failure, or congestive heart failure (CHF), means the heart can't pump enough blood. Learn about the signs, symptoms, and causes.
More about Heart Failure on MedlinePlus
Heart Failure trials in other cities
- New York City, NY51 studies
- Boston, MA44 studies
- Dallas, TX42 studies
- Houston, TX36 studies
- Cleveland, OH33 studies
- Chicago, IL31 studies
- Philadelphia, PA31 studies
- San Francisco, CA29 studies
- Durham, NC26 studies
- St. Louis, MO26 studies
- Atlanta, GA25 studies
- Kansas City, MO25 studies
Other studies in North Charleston
- Obesity11 studies
- Overweight6 studies
- Type 2 Diabetes5 studies
- Crohn's Disease4 studies
- Non-Muscle Invasive Bladder Cancer3 studies
- Attention Deficit Hyperactivity Disorder3 studies
- Hyperuricemia3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.